MusclePharm Corp (MSLP) financial statements (2022 and earlier)

Company profile

Business Address 4721 IRONTON STREET
DENVER, CO 80239
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 2,0031,5326,2284,9437,0811,020
Cash and cash equivalents 2,0031,5326,2284,9437,0811,020
Receivables 7,4884,80716,66813,35322,00316,644
Inventory, net of allowances, customer advances and progress billings 1,0324,7206,4848,56812,54921,069
Inventory 1,0324,7206,4848,56812,54921,069
Prepaid expense   89   
Other undisclosed current assets 1,3411,1049931,9305,6467,684
Total current assets: 11,86412,16330,46228,79447,27946,417
Noncurrent Assets
Operating lease, right-of-use asset 4741,175
Property, plant and equipment 132161,8223,2436,6937,805
Long-term investments and receivables     977 
Long-term investments     977 
Intangible assets, net (including goodwill) 3566761,3171,6388,6527,074
Intangible assets, net (excluding goodwill) 3566761,3171,6388,6527,074
Other noncurrent assets 295310225421180108
Other undisclosed noncurrent assets      4,952
Total noncurrent assets: 1,1382,3773,3645,30216,50219,939
TOTAL ASSETS: 13,00214,54033,82634,09663,78166,356
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 14,72530,98319,50318,67652,17834,784
Accounts payable 14,71926,17811,7429,62539,65227,761
Accrued liabilities 64,8057,7619,05112,5267,023
Debt 10,88110,184   8,164
Restructuring reserve   5956149,140 
Other undisclosed current liabilities 6,4013748,38519,1465,970(118)
Total current liabilities: 32,00741,54128,48338,43667,28842,830
Noncurrent Liabilities
Long-term debt and lease obligation 1,30872316,8153326,282292
Long-term debt, excluding current maturities 965 16,6693325,952146
Capital lease obligations146 330146
Operating lease, liability 343723
Liabilities, other than long-term debt   120208279 
Restructuring reserve   120208279 
Other undisclosed noncurrent liabilities 3,763(495)942  (146)
Total noncurrent liabilities: 5,41495117,8775406,561146
Total liabilities: 37,42142,49246,36038,97673,84942,976
Stockholders' equity
Stockholders' equity attributable to parent (24,419)(27,952)(12,534)(4,880)(10,068)23,380
Common stock 323114141414
Treasury stock, value (10,039)(10,039)(10,039)(10,039)(10,039)(10,039)
Additional paid in capital 178,261177,914159,608156,301147,646129,130
Accumulated other comprehensive loss   (150)(162)(172)(66)
Accumulated deficit (192,673)(195,858)(161,967)(150,994)(147,517)(95,659)
Total stockholders' equity: (24,419)(27,952)(12,534)(4,880)(10,068)23,380
TOTAL LIABILITIES AND EQUITY: 13,00214,54033,82634,09663,78166,356

Income statement (P&L) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues 64,44079,667102,155132,499166,858177,389
Revenue, net102,155132,499166,858177,389
Cost of revenue
(Cost of Goods and Services Sold)
 (44,831)(70,979)(71,710)(88,026)(109,927)(121,379)
Gross profit: 19,6098,68830,44544,47356,93156,010
Operating expenses (17,007)(23,795)(37,634)(53,131)(106,878)(75,386)
Operating income (loss): 2,602(15,107)(7,189)(8,658)(49,947)(19,376)
Nonoperating income (expense)  147(4,883)(1,712)(1,754)5,577
Investment income, nonoperating  383(837)  5,735
Foreign currency transaction gain (loss), before tax  (236)26   
Debt instrument, convertible, beneficial conversion feature    60152 
Other nonoperating income (expense)   (4,072)(2,313)(1,806)5,577
Interest and debt expense 659(3,609)(3,215)(702) (8)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes (95)(272)4,4577,913(52)8
Income (loss) from continuing operations before equity method investments, income taxes: 3,166(18,841)(10,830)(3,159)(51,753)(13,799)
Other undisclosed loss from continuing operations before income taxes   (1)   
Income (loss) from continuing operations before income taxes: 3,166(18,841)(10,831)(3,159)(51,753)(13,799)
Income tax expense (benefit) 19(86)108(318)(105)(33)
Net income (loss): 3,185(18,927)(10,723)(3,477)(51,858)(13,832)
Other undisclosed net loss attributable to parent   (250)   
Net income (loss) available to common stockholders, diluted: 3,185(18,927)(10,973)(3,477)(51,858)(13,832)

Comprehensive Income ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss): 3,185(18,927)(10,723)(3,477)(51,858)(13,832)
Comprehensive income (loss): 3,185(18,927)(10,723)(3,477)(51,858)(13,832)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent  (184)(238)10(106)(52)
Comprehensive income (loss), net of tax, attributable to parent: 3,185(19,111)(10,961)(3,467)(51,964)(13,884)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: